FDA Advisory Committee Votes for Co-Prescribing Naloxone with Opioids

Article Excerpt: With a vote of 12-11, the joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM) voted in favor of adding labeling language that recommends co-prescription of naloxone for all or some patients prescribed opioids.

Full Article: https://tinyurl.com/y7fqcodx

Article Source: RAPS